secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001683168-24-004501
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals raises ~$1.39M in registered direct offering and private placement
--------------------------------------------------------------------------------

- Priced 568,000 common shares plus warrants for 568,000 shares at $2.45 per unit, gross proceeds ~$1.39M.
- Warrants exercisable at $2.32 per share, expire 5 years from issuance; subject to 4.99%/9.99% ownership limitation.
- Offering expected to close June 27, 2024; net proceeds for working capital and general corporate purposes.
- A.G.P./Alliance Global Partners acting as financial advisor with 6.5% fee plus up to $80,000 expense reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824004501/0001683168-24-004501-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824004501/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004501

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer